- Report
- March 2025
- 110 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- July 2025
- 363 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- August 2025
- 144 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- August 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
- Report
- December 2025
- 52 Pages
Global
From €6569EUR$7,500USD£5,701GBP
- Report
- November 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- November 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- November 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- November 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more